{"id":749495,"date":"2023-04-20T08:19:39","date_gmt":"2023-04-20T12:19:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/"},"modified":"2023-04-20T08:19:39","modified_gmt":"2023-04-20T12:19:39","slug":"alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/","title":{"rendered":"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress"},"content":{"rendered":"<h2>\nFurther follow-up ILUVIEN\u00ae PALADIN data to be presented onsite at the annual Association for Research in Vision and Ophthalmology (ARVO) conference<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>ATLANTA, April  20, 2023  (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (\u201cAlimera\u201d), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that ILUVIEN<sup>\u00ae<\/sup> will be highlighted in four posters to be presented at the annual Association for Research in Vision and Ophthalmology (ARVO) conference being held in New Orleans, Louisiana from April 23-27, 2023.<\/p>\n<p>\n        <strong>Key ILUVIEN Abstracts (presented as posters):<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:10pt\">Veeral Sheth, M.D., \u201cLong Term Outcomes in Eyes Requiring IOP Lowering Surgery After Treatment with the 0.19 mg Fluocinolone Acetonide Implant for DME: The PALADIN Study\u201d<\/li>\n<li>Jorge Fortun, M.D., \u201cLong Term Outcomes in Eyes Requiring IOP Lowering Surgery After Treatment with the 0.19 mg Fluocinolone Acetonide Implant for DME: The PALADIN Study\u201d\n<\/li>\n<li style=\"margin-bottom:10pt\">Joseph Coney, M.D. and Sarah Godel, \u201cLong Term Outcomes in Eyes Requiring IOP Lowering Surgery After Treatment with the 0.19 mg Fluocinolone Acetonide Implant for DME: The PALADIN Study\u201d<\/li>\n<\/ul>\n<p>ARVO is among the largest vision research meetings held annually in the field of ophthalmology. Annual meeting educational content is planned by the ARVO program committee, and ARVO does not endorse, promote, approve or recommend the use of any products, devices or services.<\/p>\n<p>\n        <strong>About PALADIN<\/strong><br \/>\n        <br \/>The PALADIN\u00a0study was a phase 4, open-label, prospective, observational study conducted over 36 months at 41 sites across the United States. This study was designed and\u00a0developed to confirm the benefit of using a prior course of corticosteroid as indicated in the ILUVIEN U.S. label, to mitigate the risk of uncontrolled IOP elevation.\u00a0Researchers enrolled 202 eyes in 159 patients\u00a0with DME who had previously received corticosteroid treatment without a clinically significant rise in IOP. All eyes were treated with\u00a0ILUVIEN\u00a0and patients were followed for up to 36 months. Additionally, secondary outcomes confirmed improvement in vision and reduction in treatment burden and retinal thickness variability.<\/p>\n<p>\n        <strong>About Alimera <\/strong><br \/>\n        <br \/>Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7ZX4yAx2ydNf2Qmvn2o2Ovp9bxo3tPHifZAqDlm27aNiQEpc-uz5MQbSl2FgzqJa9Gd0WWQXx9gHgprxcasbU2OjUD27KtDkCavzpNmu5JI=\" rel=\"nofollow noopener\" target=\"_blank\">www.alimerasciences.com<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:40%;width:40%;min-width:40%;vertical-align: top\">\n            <strong>For press inquiries:<\/strong><br \/>\n            <br \/>Jules Abraham<br \/>for Alimera Sciences <br \/>917-885-7378<br \/>julesa@coreir.com<\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;vertical-align: top\">\n            <strong>For investor inquiries:<\/strong><br \/>\n            <br \/>Scott Gordon<br \/>for Alimera<br \/> scottg@coreir.com<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWMyMjk4YmUtZmY0ZC00MmY1LTk2MGEtOGQzMzg4NmNlNWMzLTEwMTU1ODY=\/tiny\/Alimera-Sciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Further follow-up ILUVIEN\u00ae PALADIN data to be presented onsite at the annual Association for Research in Vision and Ophthalmology (ARVO) conference ATLANTA, April 20, 2023 (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (\u201cAlimera\u201d), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that ILUVIEN\u00ae will be highlighted in four posters to be presented at the annual Association for Research in Vision and Ophthalmology (ARVO) conference being held in New Orleans, Louisiana from April 23-27, 2023. Key ILUVIEN Abstracts (presented as posters): Veeral Sheth, M.D., \u201cLong Term Outcomes in Eyes Requiring IOP Lowering Surgery After Treatment with the 0.19 mg Fluocinolone Acetonide Implant &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749495","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Further follow-up ILUVIEN\u00ae PALADIN data to be presented onsite at the annual Association for Research in Vision and Ophthalmology (ARVO) conference ATLANTA, April 20, 2023 (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (\u201cAlimera\u201d), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that ILUVIEN\u00ae will be highlighted in four posters to be presented at the annual Association for Research in Vision and Ophthalmology (ARVO) conference being held in New Orleans, Louisiana from April 23-27, 2023. Key ILUVIEN Abstracts (presented as posters): Veeral Sheth, M.D., \u201cLong Term Outcomes in Eyes Requiring IOP Lowering Surgery After Treatment with the 0.19 mg Fluocinolone Acetonide Implant &hellip; Continue reading &quot;Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T12:19:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress\",\"datePublished\":\"2023-04-20T12:19:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/\"},\"wordCount\":393,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/\",\"name\":\"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=\",\"datePublished\":\"2023-04-20T12:19:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/","og_locale":"en_US","og_type":"article","og_title":"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress - Market Newsdesk","og_description":"Further follow-up ILUVIEN\u00ae PALADIN data to be presented onsite at the annual Association for Research in Vision and Ophthalmology (ARVO) conference ATLANTA, April 20, 2023 (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (\u201cAlimera\u201d), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that ILUVIEN\u00ae will be highlighted in four posters to be presented at the annual Association for Research in Vision and Ophthalmology (ARVO) conference being held in New Orleans, Louisiana from April 23-27, 2023. Key ILUVIEN Abstracts (presented as posters): Veeral Sheth, M.D., \u201cLong Term Outcomes in Eyes Requiring IOP Lowering Surgery After Treatment with the 0.19 mg Fluocinolone Acetonide Implant &hellip; Continue reading \"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-20T12:19:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress","datePublished":"2023-04-20T12:19:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/"},"wordCount":393,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/","name":"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=","datePublished":"2023-04-20T12:19:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTg3MCM1NTM3MzI3IzIwMDQwMTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-data-to-be-featured-in-scientific-programming-at-upcoming-annual-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749495"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749495\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}